The emergence of the SARS-CoV-2 Omicron BA. 1 (B. 1.1. 529) variant has raised questions
regarding resistance to neutralizing antibodies elicited by natural infection or immunization …

Abstract The SARS-CoV-2 Omicron variant has been partitioned into four sub-lineages
designated BA. 1, BA. 1.1, BA. 2 and BA. 3, with BA. 2 becoming dominant worldwide …

Abstract The SARS-CoV-2 Omicron variant (B. 1.1. 529) has three major lineages BA. 1, BA.
2, and BA. 3 1. BA. 1 rapidly became dominant and has demonstrated substantial escape …

Neutralization of Omicron BA. 1 and BA. 2 Variants Although two doses of BNT162b2
vaccine produce immunity that wanes over time, the administration of a booster dose …

Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage …

Introduction SARS-CoV-2 vaccines production and distribution enabled the return to
normalcy worldwide, but it was not fast enough to avoid the emergence of variants capable …

Abstract The SARS-CoV-2 Omicron variant of concern comprises three sublineages
designated BA. 1, BA. 2, and BA. 3, with BA. 2 steadily replacing the globally dominant BA …

Summary The SARS-CoV-2 Omicron variant has evolved into four sub-lineages—BA. 1, BA.
1.1, BA. 2, and BA. 3—with BA. 2 becoming dominant worldwide. We and others have …

Monoclonal antibody therapy for the treatment of SARS-CoV-2 infection has been highly
successful in decreasing disease severity; however, the recent emergence of the heavily …

The Omicron variant is rapidly becoming the dominant SARS-CoV-2 virus circulating
globally. It is important to define reductions in virus neutralizing activity in the serum of …